Vir Biotechnology Enhances Leadership with New CFO Appointment
Vir Biotechnology Inc. has taken a significant step in strengthening its executive team by appointing Jason O’Byrne as the Chief Financial Officer (CFO). This appointment is set to take effect on October 2, 2024. Mr. O’Byrne will be joining the executive management team and will directly report to CEO Marianne De Backer.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
